Sick leave due to COVID-19 during the first pandemic wave in France, 2020.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
05 2023
Historique:
received: 03 05 2022
accepted: 17 02 2023
medline: 17 4 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

To quantify the burden of COVID-19-related sick leave during the first pandemic wave in France, accounting for sick leaves due to symptomatic COVID-19 ('symptomatic sick leaves') and those due to close contact with COVID-19 cases ('contact sick leaves'). We combined data from a national demographic database, an occupational health survey, a social behaviour survey and a dynamic SARS-CoV-2 transmission model. Sick leave incidence from 1 March 2020 to 31 May 2020 was estimated by summing daily probabilities of symptomatic and contact sick leaves, stratified by age and administrative region. There were an estimated 1.70M COVID-19-related sick leaves among France's 40M working-age adults during the first pandemic wave, including 0.42M due to COVID-19 symptoms and 1.28M due to COVID-19 contacts. There was great geographical variation, with peak daily sick leave incidence ranging from 230 in Corse (Corsica) to 33 000 in Île-de-France (the greater Paris region), and greatest overall burden in regions of north-eastern France. Regional sick leave burden was generally proportional to local COVID-19 prevalence, but age-adjusted employment rates and contact behaviours also contributed. For instance, 37% of symptomatic infections occurred in Île-de-France, but 45% of sick leaves. Middle-aged workers bore disproportionately high sick leave burden, owing predominantly to greater incidence of contact sick leaves. France was heavily impacted by sick leave during the first pandemic wave, with COVID-19 contacts accounting for approximately three-quarters of COVID-19-related sick leaves. In the absence of representative sick leave registry data, local demography, employment patterns, epidemiological trends and contact behaviours can be synthesised to quantify sick leave burden and, in turn, predict economic consequences of infectious disease epidemics.

Identifiants

pubmed: 36914254
pii: oemed-2022-108451
doi: 10.1136/oemed-2022-108451
pmc: PMC10176331
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

268-272

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Public Health. 2021 May 31;21(1):1023
pubmed: 34059034
Euro Surveill. 2021 Dec;26(48):
pubmed: 34857064
Front Public Health. 2020 Oct 19;8:580546
pubmed: 33194983
BMJ. 2021 Mar 3;372:n471
pubmed: 33658183
Glob Public Health. 2020 Jul;15(7):925-934
pubmed: 32396447
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):853-858
pubmed: 32644979
Health Aff (Millwood). 2020 Dec;39(12):2197-2204
pubmed: 33058691
Vaccines (Basel). 2022 Mar 19;10(3):
pubmed: 35335111
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
J Infect Public Health. 2020 Jun;13(6):843-848
pubmed: 32493671

Auteurs

David R M Smith (DRM)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France david.smith@ndph.ox.ac.uk.
Epidemiology & Modelling of Antibiotic Evasion, Institut Pasteur, Université Paris-Cité, Paris 75015, France.
Anti-Infective Evasion & Pharmacoepidemiology, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-le-Bretonneux 78180, France.

Sofía Jijón (S)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris 75015, France.

Ajmal Oodally (A)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Epidemiology & Modelling of Antibiotic Evasion, Institut Pasteur, Université Paris-Cité, Paris 75015, France.
Anti-Infective Evasion & Pharmacoepidemiology, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-le-Bretonneux 78180, France.

George Shirreff (G)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Epidemiology & Modelling of Antibiotic Evasion, Institut Pasteur, Université Paris-Cité, Paris 75015, France.
Anti-Infective Evasion & Pharmacoepidemiology, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-le-Bretonneux 78180, France.

Karim Aït Bouziad (K)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Pearl Anne Ante-Testard (PA)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris 75015, France.

Jonathan Bastard (J)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Epidemiology & Modelling of Antibiotic Evasion, Institut Pasteur, Université Paris-Cité, Paris 75015, France.
Anti-Infective Evasion & Pharmacoepidemiology, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-le-Bretonneux 78180, France.
Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris 75015, France.

Hanifa Bouziri (H)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Oumou Salama Daouda (OS)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Tom Duchemin (T)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Anne-Sophie Godon-Rensonnet (AS)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Paul Henriot (P)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris 75015, France.

Yasmine Houri (Y)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Hélène Neynaud (H)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Anne Perozziello (A)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Frédérique Thonon (F)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Pascal Crépey (P)

Arènes - UMR 6051, RSMS - U 1309, Université de Rennes, EHESP, CNRS, Inserm, Rennes 35000, France.

William Dab (W)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Kévin Jean (K)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.
Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris 75015, France.
MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.

Laura Temime (L)

Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris 75003, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH